BETTELLI, Stefania Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 7.802
EU - Europa 3.420
AS - Asia 2.785
SA - Sud America 434
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 14.505
Nazione #
US - Stati Uniti d'America 7.707
GB - Regno Unito 1.002
SG - Singapore 842
CN - Cina 833
IT - Italia 637
HK - Hong Kong 399
DE - Germania 390
BR - Brasile 357
SE - Svezia 354
IE - Irlanda 285
VN - Vietnam 190
UA - Ucraina 151
RU - Federazione Russa 149
FI - Finlandia 128
TR - Turchia 117
IN - India 72
ID - Indonesia 62
FR - Francia 61
JP - Giappone 60
BG - Bulgaria 57
CA - Canada 55
KR - Corea 50
NL - Olanda 41
PL - Polonia 39
AR - Argentina 35
MX - Messico 28
BE - Belgio 22
PK - Pakistan 21
BD - Bangladesh 19
LT - Lituania 19
ZA - Sudafrica 19
IQ - Iraq 18
MY - Malesia 15
AT - Austria 14
CZ - Repubblica Ceca 14
IR - Iran 11
EC - Ecuador 9
CL - Cile 8
CO - Colombia 8
ES - Italia 8
DK - Danimarca 7
EG - Egitto 7
RO - Romania 7
SA - Arabia Saudita 7
TW - Taiwan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
EU - Europa 5
GR - Grecia 5
IL - Israele 5
MA - Marocco 5
NP - Nepal 5
PY - Paraguay 5
JO - Giordania 4
KE - Kenya 4
NO - Norvegia 4
PH - Filippine 4
TH - Thailandia 4
TZ - Tanzania 4
AM - Armenia 3
AU - Australia 3
BO - Bolivia 3
DZ - Algeria 3
GA - Gabon 3
GE - Georgia 3
KZ - Kazakistan 3
LB - Libano 3
LK - Sri Lanka 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
JM - Giamaica 2
ME - Montenegro 2
MK - Macedonia 2
MT - Malta 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
UG - Uganda 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GN - Guinea 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
Totale 14.495
Città #
Fairfield 817
Santa Clara 755
Ashburn 692
Southend 660
Singapore 585
Chandler 497
Woodbridge 437
Hong Kong 390
Houston 357
Seattle 344
Ann Arbor 294
Cambridge 284
Dublin 284
Wilmington 266
Jacksonville 262
Dearborn 260
Nyköping 226
Hefei 202
Beijing 175
London 167
Chicago 146
Los Angeles 141
New York 120
Dallas 111
Modena 107
Munich 83
Salt Lake City 74
Ho Chi Minh City 71
Izmir 68
Helsinki 64
The Dalles 63
Princeton 60
San Diego 58
Sofia 57
Tokyo 54
Moscow 51
Eugene 50
Jakarta 47
Seoul 44
Council Bluffs 43
Shanghai 43
Bologna 40
Milan 40
Hanoi 39
Tampa 37
São Paulo 36
Buffalo 35
Fremont 32
Elk Grove Village 31
Falls Church 31
Rome 28
Turku 27
Bremen 24
Columbus 24
Warsaw 24
Dong Ket 23
Sterling 23
Orem 22
Ottawa 22
Phoenix 19
Brussels 18
Frankfurt am Main 18
Redwood City 17
Norwalk 16
Brooklyn 15
Lahore 15
Redondo Beach 15
Boston 14
Lancaster 14
Mexico City 14
Nuremberg 14
Denver 13
Parma 13
Stockholm 12
Brno 11
Lansdale 11
Naples 11
Atlanta 10
Hyderabad 10
Des Moines 9
Grafing 9
Johannesburg 9
Kunming 9
Nanjing 9
Reggio Emilia 9
San Francisco 9
San Giuliano Milanese 9
Ankara 8
Belo Horizonte 8
Boardman 8
Charleston 8
Curitiba 8
Guangzhou 8
Lauterbourg 8
Mumbai 8
Padova 8
Poplar 8
Portsmouth 8
Toronto 8
Amsterdam 7
Totale 10.502
Nome #
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour 380
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 372
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 372
Poorly differentiated clusters (PDC) in colorectal cancer: What is and ought to be known. 371
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 367
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 367
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 350
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 319
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 317
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 313
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 298
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 288
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 281
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 279
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 278
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 272
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 268
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 267
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 266
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 263
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 253
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 253
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients 250
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 249
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 249
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 249
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 248
Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. 248
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 244
Expression of estrogen receptor in hemangioma of the uterine cervix: Reports of three cases and review of the literature 239
Cerebrospinal fluid cytology in a case of primary diffuse leptomeningeal and pineal melanocytic lesion, with histological confirmation 234
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. 231
Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization 218
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 218
Clinical impact and prognostic role of KRAS/BRAF/PIK3CA mutations in stage I colorectal cancer 211
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 210
Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer. 208
EGFR polysomy in squamous cell carcinoma of the thyroid. Report of two cases and review of the literature 208
The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung 205
Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung 204
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 204
Prediction of Distant Recurrence-Free Survival in Resectable Lung Adenocarcinoma. 201
Preoperative letrozole plus lapatinib/placebo for HR+/HER2 negative operable breast cancer: biomarker analyses of the randomized phase II LET-LOB study 200
High-Resolution Melting is a sensitive, cost-effective, time-saving technique for BRAF V600E detection in thyroid FNAB washing fluid: a prospective cohort study 200
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 195
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 186
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 183
Correlation between CD133 expression and mgmt status in recurrences melanoma 181
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting 170
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 168
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 167
FISH analysis in cell touch preparations and cytological specimens from formalin-fixed fetal autopsies 165
Evaluation of the effects of cryopreservation on Modena Biobank tissue samples through HR-MAS NMR 162
KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: Observational analysis of 175 cases 159
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 151
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 150
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 148
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 147
Morphological analysis of three extrathoracic bronchogenic cysts simulating neoplasms 135
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report 128
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas 126
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience 98
Correction to: Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy (British Journal of Cancer, (2010), 103, 7, (1019-1024), 10.1038/sj.bjc.6605853) 54
A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients 42
Totale 14.637
Categoria #
all - tutte 56.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021866 0 0 0 0 0 89 103 182 103 173 114 102
2021/20221.179 52 128 94 71 40 91 54 58 121 123 202 145
2022/20231.520 149 164 117 122 121 178 35 115 400 13 46 60
2023/2024937 18 53 47 91 160 68 194 114 23 21 55 93
2024/20252.807 77 30 78 217 565 446 201 159 313 138 220 363
2025/20263.127 410 192 492 727 1.147 159 0 0 0 0 0 0
Totale 14.637